surmount-1 trial tirzepatide obesity without diabetes weight loss after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Tirzepatide may lead weight loss
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27

























